Sees Galafold revenue growth 10%-15%; Sees Pombiliti + Opfolda Growth 65%-85%; Sees gross margin mid 80%; Sees non-GAAP operating expenses $350M-$370M; Sees GAAP net income positive during 2H25.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.